Drug Channels

OCTOBER 5, 2021

I am pleased to announce our new 2021–22 Economic Report on Pharmaceutical Wholesalers and Specialty Distributors , available for purchase and immediate download. pharmaceutical distribution industry. reviews AmerisourceBergen’s entry into the European distribution market. (We Copyright © 2006-2021 Pembroke Consulting, Inc.

Pharmaceuticals 75

Pharmaceuticals Biosimilars Licensing Licensing 75

Drug Channels

OCTOBER 10, 2023

I am pleased to announce our new 2023–24 Economic Report on Pharmaceutical Wholesalers and Specialty Distributors , available for purchase and immediate download. pharmaceutical distribution industry. we analyze the IRA’s likely consequences for wholesalers and the overall pharmaceutical business. In Subsection 6.5.1.,

Pharmaceuticals 40

Pharmaceuticals Specialty Pharmacies Pharmacy Biosimilars 40

Drug Channels

APRIL 8, 2022

Michael discusses patient support challenges that are unique to specialty-lite pharmaceuticals. He goes on to describe four new categories of patient solutions and pharmacy models specific to this growing market segment. Read more » Copyright © 2006-2022 Pembroke Consulting, Inc. Read on for Michael’s insights.

Specialty Pharmacies 96

Specialty Pharmacies Production Pharmacy Pharmaceuticals 96

Drug Channels

OCTOBER 5, 2023

This week, I’m rerunning some popular posts while I put the finishing touches on DCI's new 2023-24 Economic Report on Pharmaceutical Wholesalers and Specialty Distributors. During the full 90-minute webinar, I discussed seven crucial risks that could disrupt this market along with many other aspects of this emerging market.

Pharmaceuticals 97

Pharmaceuticals Marketing Drugs 97

Drug Channels

MAY 24, 2023

In recent years, each of these companies has launched new group purchasing organizations (GPOs) to further consolidate the number of covered lives in rebate negotiations with pharmaceutical manufacturers. Read more » Copyright © 2006-2023 Pembroke Consulting, Inc. to 1:30 p.m. Click here to learn more and register.

Pharmacy 98

Pharmacy Pharmaceuticals Marketing Drugs 98

Drug Channels

JULY 29, 2022

Note that the forecasts below did not account for policy changes that could further reduce pharmaceuticals' share of U.S. What’s more, taxpayers—via Medicare and Medicaid—will continue to crowd out the private insurance market. Thus, the government actuaries expect that pharmaceuticals will not be the key driver of U.S.

Pharmacy 98

Pharmacy Government Drugs Pharmaceuticals 98

Drug Channels

SEPTEMBER 9, 2021

In Cardinal’s 2021 fiscal year, CVS purchased more than $42 billion in pharmaceuticals from the wholesaler—about double the figure from 10 years ago. The two wholesalers sell more than $90 billion in pharmaceuticals to CVS Health—making it the largest U.S. Read more » Copyright © 2006-2021 Pembroke Consulting, Inc. to 1:30 p.m.

Pharmaceuticals 98

Pharmaceuticals Marketing Drugs Pharmacy 98

Drug Channels

MAY 21, 2024

WHAT YOU WILL LEARN The federal 340B Drug Pricing Program continues to grow much more quickly than the overall pharmaceutical market. DCI estimates that 340B discounts equated to more than 17% of total value of gross-to-net reductions for brand-name pharmaceuticals. Pharmacies and Pharmacy Benefit Managers. All rights reserved.

Pharmacy 52

Pharmacy Drugs Pharmaceuticals Marketing 52

Drug Channels

APRIL 12, 2022

What’s more, taxpayers—via Medicare and Medicaid—will continue to crowd out the private insurance market. Thus, the government actuaries expect that pharmaceuticals will not be the key driver of U.S. Read more » Copyright © 2006-2022 Pembroke Consulting, Inc. healthcare spending. healthcare spending growth. to 1:30 p.m.

Pharmacy 98

Pharmacy Government Drugs Pharmaceuticals 98

Drug Discovery World

FEBRUARY 12, 2024

The arthritis drug rofecoxib (Vioxx) passed tests in several different animal species yet it caused tens of thousands of excess cases of serious coronary heart disease in the US before it was removed from the market. Clinical Development Success Rates 2006-2015.; ATLA Altern to Lab Anim. 2009;37(SUPPL.

Animal Testing 147

Animal Testing Disease Trials Research 147

The Pharma Data

AUGUST 19, 2020

Multiple Attorney Generals from across the US are seeking billions of dollars in damages to settle opioid cases against major pharmaceutical manufacturers and distributors. . New York State also says Teva made 20% of all opioids distributed from 2006 to 2014 in the region and marketed its products for off-label uses.

Pharmaceuticals 52

Pharmaceuticals Doctors International FDA 52

Drug Channels

OCTOBER 23, 2023

A program driven by market dynamics and led by champions of channel strategy, join now to master the complexities of pharmacy and distribution models to accelerate market access –It's all happening December 11-13, 2023. Why should you attend this pivotal event? How is health policy affecting the distribution channel?

Pharmacy 75

Pharmacy Biosimilars Production Marketing 75

Drug Channels

OCTOBER 13, 2020

I am pleased to announce our new 2020–21 Economic Report on Pharmaceutical Wholesalers and Specialty Distributors , available for purchase and immediate download. The 2020–21 Economic Report on Pharmaceutical Wholesalers and Specialty Distributors is the only resource of its kind available anywhere. healthcare system.

Pharmaceuticals 52

Pharmaceuticals Licensing Licensing Pharmacy 52

Drug Target Review

JUNE 19, 2024

Also, many companies never reached the point where they received validation from big pharmaceutical companies. From 2002 until 2004, Mr Culley was Director of Business Development and Marketing for Immusol, Inc. Mr Culley served on the Board of Orphagen Pharmaceuticals, Inc. from May 2017 until December 2022.

Therapies 84

Therapies Small Molecule Pharmaceutical Companies Molecular Biology 84

The Pharma Data

OCTOBER 19, 2020

20, 2020 /PRNewswire/ — CNS PHARMACEUTICALS AG , Inc. manufacturer, Pharmaceutics International, Inc. (“Pii”), has completed the manufacturing process for Berubicin Drug Product, its lead drug candidate for the treatment of glioblastoma multiforme (GBM), an aggressive form of brain cancer currently considered incurable.

Clinical Trials 52

Clinical Trials Trials Pharmaceuticals Treatment 52

Drug Channels

JULY 11, 2022

President and CEO, National Pharmaceutical Council Julie Ritchie Wagner, Senior Assistant General Counsel, Head of Global Ethics, Compliance, and Enforcement Legal Policy, PhRMA Joel White, Founder and President, Horizon Government Affairs Charlene Keller Fullmer, Assistant U.S. Copyright © 2006-2022 Pembroke Consulting, Inc.

Specialty Pharmacies 98

Specialty Pharmacies Pharmacy Biosimilars Compliance 98

Drug Channels

MAY 9, 2022

Emily Phillips, Reimbursement, Patient Advocate, & Government Affairs Leader Melissa Beatty, Director, Patient Services and Reimbursement, CTI Bio Pharma Chad Bower, Executive Director, Field Reimbursement & Oncology Solutions, US Market Access, Daiichi Sankyo, Inc. Copyright © 2006-2022 Pembroke Consulting, Inc. Attorney, U.S.

Specialty Pharmacies 75

Specialty Pharmacies Pharmacy Pharmaceuticals Government 75

The Premier Consulting Blog

JULY 9, 2023

These evaluations include the active pharmaceutical ingredient (API), also known as the drug substance, and the drug product (formulated product). ICH M7 (R1) Assessment and control of DNA reactive (mutagenic) impurities in pharmaceuticals to limit potential carcinogenic risk – Scientific guideline. link] ICH M7 (R2)- Q&A.

Small Molecule 52

Small Molecule DNA Drugs Clinical Development 52

Drug Channels

MARCH 15, 2022

Prescription Market (press release) We’re offering special discounted pricing if you order before March 28, 2022. As always, we have updated all market and industry data with the most current information available, including our annual analyses of the market positions of the largest pharmacies, specialty pharmacies, and PBMs.

Pharmacy 98

Pharmacy Specialty Pharmacies Licensing Licensing 98

Drug Channels

SEPTEMBER 18, 2023

Attorney’s Office for the Eastern District of Pennsylvania Suzanne Marinakos, Director, Patient Services Operations- Rare Disease , Novo Nordisk Snigdha Santra, Director, Business Insights and Strategy , Chugai Pharmaceuticals Kinshuk Saxena, Pharm.D., Copyright © 2006-2023 Pembroke Consulting, Inc. d/b/a Drug Channels Institute.

Compliance 75

Compliance Pharmaceuticals Disease Drugs 75

Drug Channels

MARCH 19, 2023

Copyright © 2006-2023 Pembroke Consulting, Inc. Drug Channels, or any of its employees. To find out how you can promote an event on Drug Channels, please contact Paula Fein (paula@drugchannels.net). d/b/a Drug Channels Institute. Drug Channels® is a registered trademark of Pembroke Consulting, Inc.

Science 75

Science Government Pharmaceuticals Production 75

Drug Channels

JULY 20, 2021

The 340B Drug Pricing Program continues to expand far more quickly than the overall pharmaceutical market—and some channels are benefiting more than others. That’s about six times faster than the overall mail and specialty market. Consequently, specialty pharmacies have gained a greater share of the 340B market.

Specialty Pharmacies 52

Specialty Pharmacies Pharmacy Marketing Pharmaceuticals 52

The Pharma Data

JULY 22, 2021

Teva Pharmaceutical Industries Ltd. Sven has played an integral role in optimizing Teva’s vast global portfolio, in the R&D pipeline strategy, and leading global marketing teams including responsibility for AJOVY ® , AUSTEDO ® and Digital Health. NYSE and TASE: TEVA) today announced changes to its leadership team.

International 52

International Marketing Engineering Pharmaceuticals 52

Drug Channels

OCTOBER 30, 2023

Copyright © 2006-2023 Pembroke Consulting, Inc. The content of Sponsored Posts does not necessarily reflect the views of Pembroke Consulting, Inc., Drug Channels, or any of its employees. To find out how you can promote an event on Drug Channels, please contact Paula Fein (paula@drugchannels.net). d/b/a Drug Channels Institute.

Pharmaceutical Companies 74

Pharmaceutical Companies Regulations Pharmaceuticals Drugs 74

Drug Channels

DECEMBER 1, 2020

During 2020, the COVID-19 pandemic disrupted every aspect of the pharmaceutical channel—and our lives. Pharmacy and healthcare provider markets experienced unprecedented volatility. Pharmaceutical wholesalers have maintained shipments and operational capacity. Read more » Copyright © 2006-2020 Pembroke Consulting, Inc.

Pharmacy 52

Pharmacy Vaccine Drugs Pharmaceuticals 52

Drug Channels

SEPTEMBER 21, 2020

Executive Director , National Association of Specialty Pharmacy (NASP) David Kowalsky, Director, Market Access and Patient Services , EyePoint Pharmaceuticals Andrew Gettinger, Chief Clinical Officer , ONC at US Department of Health & Human Services And more! Copyright © 2006-2020 Pembroke Consulting, Inc. Arquette, R.Ph.,

Specialty Pharmacies 52

Specialty Pharmacies Pharmacy Pharmaceuticals Production 52

Drug Channels

JUNE 1, 2020

Virtual business sessions cover such topics as market trends, the specialty pipeline, accreditation, federal health policy, digital health, and more. Two highlights: The State of Specialty Pharmacy 2020: Market Data and Trends —Adam J. Copyright © 2006-2020 Pembroke Consulting, Inc. Fein, Drug Channels Institute (That’s me!)

Specialty Pharmacies 40

Specialty Pharmacies Pharmacy Pharmaceuticals Marketing 40

The Pharma Data

APRIL 4, 2023

With eight marketed biosimilars Sandoz is offering the broadest biosimilar portfolio and is the leading biosimilars company in Europe with more than two decades of experience. It has a leading global portfolio with eight marketed biosimilars and a further 15+ in various stages of development.

Biosimilars 40

Biosimilars Pharmacokinetics FDA Approval Packaging 40

Drug Channels

NOVEMBER 23, 2020

Copyright © 2006-2020 Pembroke Consulting, Inc. The content of Sponsored Posts does not necessarily reflect the views of Pembroke Consulting, Inc., Drug Channels, or any of its employees. d/b/a Drug Channels Institute. Drug Channels® is a registered trademark of Pembroke Consulting, Inc. This Feed is for personal non-commercial use only.

Pharmaceuticals 40

Pharmaceuticals Marketing Drugs 40

Drug Channels

AUGUST 11, 2020

Time for our annual update on pricing at five of the largest pharmaceutical manufacturers—Eli Lilly, Janssen, Merck, Novartis, and Sanofi. Read more » Copyright © 2006-2020 Pembroke Consulting, Inc. You can find links to each company’s data below. When rebates and discounts were factored in, drug prices declined—or grew slowly—in 2019.

Government 52

Government Pharmaceuticals Drugs Marketing 52

Drug Channels

MARCH 14, 2022

The Summit will again welcome the full spectrum of organizations working in the pharmacy, life sciences & patient services market. Copyright © 2006-2022 Pembroke Consulting, Inc. Send it to connect@asembiasummit.com. for consideration. Drug Channels, or any of its employees. d/b/a Drug Channels Institute.

Specialty Pharmacies 74

Specialty Pharmacies Pharmacy FDA Science 74

Drug Channels

MAY 3, 2021

Copyright © 2006-2021 Pembroke Consulting, Inc. and more! * Expires 6/25/20210; applies to standard rate only and may not be combined or applied to existing registrations; other restrictions may apply. The content of Sponsored Posts does not necessarily reflect the views of Pembroke Consulting, Inc., Drug Channels, or any of its employees.

Pharmacy 40

Pharmacy Government Pharmaceuticals Science 40

Drug Channels

NOVEMBER 8, 2020

Copyright © 2006-2020 Pembroke Consulting, Inc. Stuart Parker, Senior Director, Trade Relations, Mayne Pharma And more! Other restrictions may apply. The content of Sponsored Posts does not necessarily reflect the views of Pembroke Consulting, Inc., Drug Channels, or any of its employees. d/b/a Drug Channels Institute.

Specialty Pharmacies 52

Specialty Pharmacies Science Pharmacy Pharmaceuticals 52

The Pharma Data

MAY 15, 2023

Before joining Solvias Group, Karen held various senior leadership roles at Novartis, including global head investor relations from 2000 to 2006, head M&A and Executive Committee member, as well as site head for the Vaccines & Diagnostics division between 2006 and 2011. the world’s largest food company, since 2015.

Science 40

Science Doctors Government Compliance 40

Drug Channels

OCTOBER 26, 2020

You’ll hear perspectives from companies such as ADC Therapeutics, Alkermes, Amgen, Apellis Pharmaceuticals, Bristol-Myers Squibb, Cipla Therapeutics, Deloitte & Touche LLP, Eisai US, Eli Lilly & Co, IntegriChain, Intra-Cellular Therapies, MyoKardia, Paratek Pharmaceuticals and Teva Pharmaceuticals.

Government 40

Government Pharmaceuticals Science Production 40

Drug Channels

OCTOBER 19, 2020

Copyright © 2006-2020 Pembroke Consulting, Inc. Other restrictions may apply. The content of Sponsored Posts does not necessarily reflect the views of Pembroke Consulting, Inc., Drug Channels, or any of its employees. d/b/a Drug Channels Institute. Drug Channels® is a registered trademark of Pembroke Consulting, Inc.

Specialty Pharmacies 52

Specialty Pharmacies Science Pharmacy Licensing 52

Agency IQ

NOVEMBER 10, 2023

Services incurring fees include marketing authorization applications, variations, scientific advice, and inspections. Fees supplemental to the basic fees can be collected for authorization of additional strengths and pharmaceutical forms. literature monitoring), since national regulators charge their own fees.

Regulations 40

Regulations Pharmaceuticals Government Therapies 40